Harnessing the value of TCTP in breast cancer treatment resistance: an opportunity for personalized therapy

Early identification of breast cancer (BC) patients at a high risk of progression may aid in therapeutic and prognostic aims. This is especially true for metastatic disease, which is responsible for most cancer-related deaths. Growing evidence indicates that the translationally controlled tumor prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Santamaria, Gianluca, Cioce, Mario, Rizzuto, Antonia, Fazio, Vito Michele, Viglietto, Giuseppe, Lucibello, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571059/
https://www.ncbi.nlm.nih.gov/pubmed/37842235
http://dx.doi.org/10.20517/cdr.2023.21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571059/
https://www.ncbi.nlm.nih.gov/pubmed/37842235
http://dx.doi.org/10.20517/cdr.2023.21

Ejemplares similares